Post-IPO Debt - Verona Pharma
Investment Firm
Overview
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Announced Date
Jan 02, 2024
Funding Type
Post Ipo Debt
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Verona Pharma raised $400000000 on 2024-01-02 in Post-IPO Debt
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 02, 2024 |  Post-IPO Debt - Verona Pharma | 2 | - | 400.0M |
| May 09, 2024 | Post-IPO Debt - Verona Pharma | 2 | - | 650.0M |
| Jun 20, 2016 | Post-IPO Equity - Verona Pharma | 9 | - | 65.6M |
| Feb 06, 2012 | Post-IPO Equity - Verona Pharma | 1 | - | 11.5M |
Recent Activity
There is no recent news or activity for this profile.